AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Gonzalez-Paz, O Polizzi, D De Cesare, M Zunino, F Bigioni, M Maggi, CA Manzini, S Pratesi, G
Citation: O. Gonzalez-paz et al., Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude mice, EUR J CANC, 37(3), 2001, pp. 431-437

Authors: Perego, P Corna, E De Cesare, M Gatti, L Polizzi, D Pratesi, G Supino, R Zunino, F
Citation: P. Perego et al., Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines, CURR MED CH, 8(1), 2001, pp. 31-37

Authors: Moretti, RM Marelli, MM Motta, M Polizzi, D Monestiroli, S Pratesi, G Limonta, P
Citation: Rm. Moretti et al., Activation of the orphan nuclear receptor ROR alpha induces growth arrest in androgen-independent DU 145 prostate cancer cells, PROSTATE, 46(4), 2001, pp. 327-335

Authors: Supino, R Polizzi, D Pavesi, R Pratesi, G Guano, F Capranico, G Palumbo, M Sissi, C Richter, S Beggiolin, G Menta, E Pezzoni, G Spinelli, S Torriani, D Carenini, N Dal Bo, L Facchinetti, F Tortereto, M Zunino, F
Citation: R. Supino et al., A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts, ONCOL-BASEL, 61(3), 2001, pp. 234-242

Authors: Cassinelli, G Supino, R Perego, P Polizzi, D Lanzi, C Pratesi, G Zunino, F
Citation: G. Cassinelli et al., A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes, INT J CANC, 92(5), 2001, pp. 738-747

Authors: Manzotti, C Pratesi, G Menta, E Di Domenico, R Cavalletti, E Fiebig, HH Kelland, LR Farrell, N Polizzi, D Supino, R Pezzoni, G Zunino, F
Citation: C. Manzotti et al., BBR 3464: A novel triplatinum complex, exhibiting a preclinical profile ofantitumor efficacy different from cisplatin, CLIN CANC R, 6(7), 2000, pp. 2626-2634

Authors: Polizzi, D Pratesi, G Monestiroli, S Tortoreto, M Zunino, F Bombardelli, E Riva, A Morazzoni, P Colombo, T D'Incalci, M Zucchetti, M
Citation: D. Polizzi et al., Oral efficacy and bioavailability of a novel taxane, CLIN CANC R, 6(5), 2000, pp. 2070-2074

Authors: Seidita, G Polizzi, D Costanzo, G Costa, S Di Leonardo, A
Citation: G. Seidita et al., Differential gene expression in p53-mediated G(1) arrest of human fibroblasts after gamma-irradiation or N-phosphoacetyl-L-aspartate treatment, CARCINOGENE, 21(12), 2000, pp. 2203-2210

Authors: Pratesi, G Polizzi, D Perego, P Dal Bo, L Zunino, F
Citation: G. Pratesi et al., Bcl-2 phosphorylation in a human breast carcinoma xenograft: A common event in response to effective DNA-damaging drugs, BIOCH PHARM, 60(1), 2000, pp. 77-82

Authors: Cassinelli, G Lanzi, C Pensa, T Gambetta, RA Nasini, G Cuccuru, G Cassinis, M Pratesi, G Polizzi, D Tortoreto, M Zunino, F
Citation: G. Cassinelli et al., Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin, BIOCH PHARM, 59(12), 2000, pp. 1539-1547

Authors: Zunino, F Cassinelli, G Polizzi, D Perego, P
Citation: F. Zunino et al., Molecular mechanisms of resistance to taxanes and therapeutic implications, DRUG RESIST, 2(6), 1999, pp. 351-357

Authors: Polizzi, D Pratesi, G Tortoreto, M Supino, R Riva, A Bombardelli, E Zunino, F
Citation: D. Polizzi et al., A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts, CANCER RES, 59(5), 1999, pp. 1036-1040

Authors: Pratesi, G Perego, P Polizzi, D Righetti, SC Supino, R Caserini, C Manzotti, C Giuliani, FC Pezzoni, G Tognella, S Spinelli, S Farrell, N Zunino, F
Citation: G. Pratesi et al., A novel charges trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts, BR J CANC, 80(12), 1999, pp. 1912-1919
Risultati: 1-13 |